RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
-4.7%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$706M
AUM Growth
+$706M
Cap. Flow
-$175M
Cap. Flow %
-24.8%
Top 10 Hldgs %
84.23%
Holding
36
New
6
Increased
4
Reduced
10
Closed
9

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$35M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
$20.5M
3
MYOV
Myovant Sciences Ltd.
MYOV
$18.7M
4
AVXS
AveXis, Inc. Common Stock
AVXS
$7.57M
5
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
$6.61M

Top Sells

1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
$70M
2
NKTR icon
Nektar Therapeutics
NKTR
$63M
3
ACRS icon
Aclaris Therapeutics
ACRS
$39.6M
4
ARDX icon
Ardelyx
ARDX
$18.9M
5
TGTX icon
TG Therapeutics
TGTX
$16.9M

Sector Composition

1 Healthcare 96.66%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AKTX
26
Akari Therapeutics
AKTX
$24.8M
$714K 0.1%
101,439
-12,600
-11% -$88.7K
ORKA
27
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$662K 0.09%
232,245
-289,361
-55% -$825K
ACRS icon
28
Aclaris Therapeutics
ACRS
$209M
– –
-1,547,152
Closed -$39.6M
ARCT icon
29
Arcturus Therapeutics
ARCT
$462M
– –
-2,044,756
Closed -$5.05M
ARWR icon
30
Arrowhead Research
ARWR
$3.05B
– –
-1,525,424
Closed -$11.2M
NKTR icon
31
Nektar Therapeutics
NKTR
$568M
– –
-3,664,154
Closed -$63M
SGMO icon
32
Sangamo Therapeutics
SGMO
$157M
– –
-899,438
Closed -$4.16M
SYRE icon
33
Spyre Therapeutics
SYRE
$996M
– –
-336,134
Closed -$2.16M
TARA icon
34
Protara Therapeutics
TARA
$120M
– –
-1,626,931
Closed -$15.2M
SIOX
35
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-5,000,000
Closed -$70M
XLRN
36
DELISTED
Acceleron Pharma Inc.
XLRN
– –
-318,565
Closed -$11.5M
1
2